“Our results suggest that in carriers of BRCA mutations, the immune system is failing to kill off damaged breast cells, which in turn seem to be working to keep these immune cells at bay,” says Cambridge University's Dr. Khaled: bit.ly/3U2uQuj #CancerResearch #BreastCancer

According to Wilmot Cancer Institute and UNC Lineberger research, published in Annals of American Thoracic Society (ATS), nearly half of patients with positive lung cancer screening findings delay follow-up care. Learn more in Healio: bit.ly/48YhG5G #LungCancer #EarlyDetection #CancerResearch

Join us in the fight against cancer and your donation will be matched up to $300,000 by a group of generous donors, only until June 30, 2024. Make a gift today to the Cancer Research Institute, and double your impact: bit.ly/3Pv3FFB #CancerResearch #Immunotherapy

Can a blood sample be used to predict patient outcomes to #cancer #immunotherapy drug pembrolizumab? Researchers Enrique Sanz-Garcia, Eric Stutheit-Zhao and Lillian Siu from Princess Margaret Cancer Centre Research investigate this in their new study. Read more > uhnresearch.ca/news/assessing…; doi.org/10.1158/2159-8…

The composition of the gut microbiomes in a group of rectal cancer patients demonstrated signatures by race, ethnicity, and age of onset, UT Southwestern Medical Center researchers noted, with white Hispanics showing significant presence of one specific type of bacteria: bit.ly/3VA5OUm

'There’s ever-growing evidence to support the use of ctDNA in the full range of the cancer care continuum. We think it’s the future,” shares CRI-Torrey Coast Foundation GEMINI CLIP Investigator Dr. Anagnostou Elsa Anagnostou Johns Hopkins Medicine. More in The ASCO Post: bit.ly/3xyIEnf

Researchers from Purdue University are developing and validating nanoparticles modified with adenosine triphosphate (ATP) to enhance immunotherapy effects against malignant tumors. Learn more about their work, published in ACS Publications: bit.ly/3xgcyN5 #Immunotherapy

How do social determinants of health such as race, ethnicity, and treatment access play a role in occurrence rates of cervical cancer in the US? Explore an analysis of the link from LSU, in Targeted Oncology: bit.ly/3Vt0SRi #HealthEquity #CancerResearch #CervicalCancer

1 in 5 new colorectal cancer patients in the US is under 55, according to a recent The Wall Street Journal analysis of data from National Cancer Institute. Discover what researchers know- and what they don't- about early-onset cancers, with Vox: bit.ly/4aLyn5y #CancerResearch #CancerPatient

In a new study, researchers from The Crick and UCL observe that examining the immune cells in the environment surrounding a tumor could help predict cancer progression and treatment response. Learn more in PharmaTimes: bit.ly/3PZFUWl #CancerResearch #Microenvironment

According to an ongoing study presented by Sylvester Comprehensive Cancer Center researchers at #AACR24 , combining immunotherapy with 'a cancer-busting virus' may offer a way forward to treat neuroendocrine tumors, a rare cancer type that's growing in incidence: bit.ly/4awZ2Dy #Immunotherapy

Aiming to facilitate early detection of head and neck cancer, U-M Rogel Cancer Center researchers created a urine-based test that detects pieces of DNA fragments released by head and neck tumors. Learn more during #HeadandNeckCancer Awareness Month: bit.ly/3vM77VP #EarlyDetection

What are the latest advancements in pancreatic cancer vaccines? Moffitt Cancer Center explores this 'new frontier in immunotherapy treatment:' bit.ly/3IT6Lzy #Immunotherapy #CancerVaccines #CancerResearch #PancreaticCancer

When will patients see personalized cancer vaccines? Dr. Catherine Wu of Harvard Medical School and Dana-Farber shares her insights into the technology, and the expectations that patients might see it in the near future, with Harvard University: bit.ly/3TS3Lss #CancerVaccine #CancerResearch

In the news today, some incredibly exciting Peter Mac research, using ovarian, breast and colon cancer models, has identified a gene that can be stimulated to make the CAR T-cells younger, fitter, more dynamic & effective in fighting solid tumours.

More: petermac.org/about-us/news-…

Bioengineered immune cells have been shown to attack and even cure cancer, but often become exhausted over time. Understand how researchers including former CRI Fellow Dr. Junyun Lai Peter Mac Cancer Centre have found a way to rejuvenate these cells: go.nature.com/4aPkzqH #CancerResearch

Explore the most recent advances in gynecologic cancer management, specifically in endometrial cancer, with CRI Clinical Accelerator Investigator Dr. Zamarin Dmitriy Zamarin MD PhD Mount Sinai Health System in an interview with OncLive.com: bit.ly/3TIW1c6 #CancerResearch #EndometrialCancer

Data presented by Vinod BalachandranMD Memorial Sloan Kettering Cancer Center at #AACR24 shows an approach to treating pancreatic cancer with an mRNA-based vaccine demonstrates potential to stimulate an immune response that may reduce the risk of the disease returning after surgery: bit.ly/3TVjzKH

Make your donation to the Cancer Research Institute go twice, or even three times as far, with your employer's matching gift program! Learn how you can magnify your impact on cancer immunotherapy research today: bit.ly/45p0bu7 #EmployerMatch #CancerResearch #MatchingGift

Aiming to unravel the complex dynamics behind both on- and off-target CRISPR edits, UC San Diego researchers created a new genetic system to test and analyze the underlying mechanisms of CRISPR-based DNA repair outcomes. Discover: bit.ly/4cAmJfL #CRISPR #CancerResearch